Item 8.01 Other Events.
On January 21, 2022, FOMO invested additional funds into GenBio, Inc. ("GenBio";
https://genbioinc.com/), a Delaware corporation that is developing and offering
nutraceutical products and formulations aimed at anti-inflammatory and reduced
blood pressure health benefits. The Companies are working on health beverages
and other products under "FOMO CAN" and other brands, to be distributed by
FOMO's minority investment Himalaya Technologies, Inc. (OTC: HMLA;
https://www.himalayatechnologies.com/) which directly owned roughly 19.9% of
GenBio's pre-money common equity.
Item 9.01. Exhibits
(a) Exhibits. The following exhibits are filed with this Current Report on Form
8-K:
Exhibit No. Description
10.1 FOMO CORP. - GenBio, Inc. Investment Agreement - January 21,
2022
10.2 FOMO CORP. - GenBio, Inc. Statement of Positions - January 27,
2022
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
© Edgar Online, source Glimpses